% alzhub.org library filter % Source: https://alzhub.org/research?author=Andreasson+U % 32 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{olsson2016-27068280, author = {Olsson, B. and Lautner, R. and Andreasson, U. and Öhrfelt, A. and Portelius, E. and Bjerke, M. and Hölttä, M. and Rosén, C. and others}, title = {{CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis}}, journal = {The Lancet. Neurology}, year = {2016}, doi = {10.1016/s1474-4422(16)00070-3}, pmid = {27068280}, url = {https://doi.org/10.1016/s1474-4422(16)00070-3} } @article{mattsson2019-31009028, author = {Mattsson, N. and Cullen, N. C. and Andreasson, U. and Zetterberg, H. and Blennow, K.}, title = {{Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.0765}, pmid = {31009028}, url = {https://doi.org/10.1001/jamaneurol.2019.0765} } @article{mattsson2017-28346578, author = {Mattsson, N. and Andreasson, U. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease}}, journal = {JAMA neurology}, year = {2017}, doi = {10.1001/jamaneurol.2016.6117}, pmid = {28346578}, url = {https://doi.org/10.1001/jamaneurol.2016.6117} } @article{mattsson2016-27694257, author = {Mattsson, N. and Zetterberg, H. and Janelidze, S. and Insel, P. S. and Andreasson, U. and Stomrud, E. and Palmqvist, S. and Baker, D. and others}, title = {{Plasma tau in Alzheimer disease}}, journal = {Neurology}, year = {2016}, doi = {10.1212/wnl.0000000000003246}, pmid = {27694257}, url = {https://doi.org/10.1212/wnl.0000000000003246} } @article{kern2018-29653987, author = {Kern, S. and Zetterberg, H. and Kern, J. and Zettergren, A. and Waern, M. and Höglund, K. and Andreasson, U. and Wetterberg, H. and others}, title = {{Prevalence of preclinical Alzheimer disease: Comparison of current classification systems}}, journal = {Neurology}, year = {2018}, doi = {10.1212/wnl.0000000000005476}, pmid = {29653987}, url = {https://doi.org/10.1212/wnl.0000000000005476} } @article{bridel2019-31206160, author = {Bridel, C. and van Wieringen, W. N. and Zetterberg, H. and Tijms, B. M. and Teunissen, C. E. and {the NFL Group} and Alvarez-Cermeño, J. C. and Andreasson, U. and others}, title = {{Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2019.1534}, pmid = {31206160}, url = {https://doi.org/10.1001/jamaneurol.2019.1534} } @article{ashton2025-39907496, author = {Ashton, N. J. and Keshavan, A. and Brum, W. S. and Andreasson, U. and Arslan, B. and Droescher, M. and Barghorn, S. and Vanbrabant, J. and others}, title = {{The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2025}, doi = {10.1002/alz.14508}, pmid = {39907496}, url = {https://doi.org/10.1002/alz.14508} } @article{olsson2019-30508027, author = {Olsson, B. and Portelius, E. and Cullen, N. C. and Å, Sandelius and Zetterberg, H. and Andreasson, U. and Höglund, K. and Irwin, D. J. and others}, title = {{Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders}}, journal = {JAMA neurology}, year = {2019}, doi = {10.1001/jamaneurol.2018.3746}, pmid = {30508027}, url = {https://doi.org/10.1001/jamaneurol.2018.3746} } @article{palmqvist2014-25155658, author = {Palmqvist, S. and Zetterberg, H. and Blennow, K. and Vestberg, S. and Andreasson, U. and Brooks, D. J. and Owenius, R. and Hägerström, D. and others}, title = {{Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography}}, journal = {JAMA neurology}, year = {2014}, doi = {10.1001/jamaneurol.2014.1358}, pmid = {25155658}, url = {https://doi.org/10.1001/jamaneurol.2014.1358} } @article{portelius2015-26373605, author = {Portelius, E. and Zetterberg, H. and Skillbäck, T. and Törnqvist, U. and Andreasson, U. and Trojanowski, J. Q. and Weiner, M. W. and Shaw, L. M. and others}, title = {{Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2015}, doi = {10.1093/brain/awv267}, pmid = {26373605}, url = {https://doi.org/10.1093/brain/awv267} } @article{alves2010-20547614, author = {Alves, G. and Brønnick, K. and Aarsland, D. and Blennow, K. and Zetterberg, H. and Ballard, C. and Kurz, M. W. and Andreasson, U. and others}, title = {{CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2010}, doi = {10.1136/jnnp.2009.199950}, pmid = {20547614}, url = {https://doi.org/10.1136/jnnp.2009.199950} } @article{zetterberg2008-18695061, author = {Zetterberg, H. and Andreasson, U. and Hansson, O. and Wu, G. and Sankaranarayanan, S. and Andersson, M. E. and Buchhave, P. and Londos, E. and others}, title = {{Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease}}, journal = {Archives of neurology}, year = {2008}, doi = {10.1001/archneur.65.8.1102}, pmid = {18695061}, url = {https://doi.org/10.1001/archneur.65.8.1102} } @article{hall2012-22925882, author = {Hall, S. and Öhrfelt, A. and Constantinescu, R. and Andreasson, U. and Surova, Y. and Bostrom, F. and Nilsson, C. and Håkan, W. and others}, title = {{Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders}}, journal = {Archives of neurology}, year = {2012}, doi = {10.1001/archneurol.2012.1654}, pmid = {22925882}, url = {https://doi.org/10.1001/archneurol.2012.1654} } @article{lewczuk2018-30055655, author = {Lewczuk, P. and Ermann, N. and Andreasson, U. and Schultheis, C. and Podhorna, J. and Spitzer, P. and Maler, J. M. and Kornhuber, J. and others}, title = {{Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0404-9}, pmid = {30055655}, url = {https://doi.org/10.1186/s13195-018-0404-9} } @article{lautner2014-25162367, author = {Lautner, R. and Palmqvist, S. and Mattsson, N. and Andreasson, U. and Wallin, A. and Pålsson, E. and Jakobsson, J. and Herukka, S. K. and others}, title = {{Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease}}, journal = {JAMA psychiatry}, year = {2014}, doi = {10.1001/jamapsychiatry.2014.1060}, pmid = {25162367}, url = {https://doi.org/10.1001/jamapsychiatry.2014.1060} } @article{vanhulle2021-33336877, author = {Van Hulle, C. and Jonaitis, E. M. and Betthauser, T. J. and Batrla, R. and Wild, N. and Kollmorgen, G. and Andreasson, U. and Okonkwo, O. and others}, title = {{An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2021}, doi = {10.1002/alz.12204}, pmid = {33336877}, url = {https://doi.org/10.1002/alz.12204} } @article{bozaserrano2022-35895141, author = {Boza-Serrano, A. and Vrillon, A. and Minta, K. and Paulus, A. and Camprubí-Ferrer, L. and Garcia, M. and Andreasson, U. and Antonell, A. and others}, title = {{Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease}}, journal = {Acta neuropathologica}, year = {2022}, doi = {10.1007/s00401-022-02469-6}, pmid = {35895141}, url = {https://doi.org/10.1007/s00401-022-02469-6} } @article{portelius2018-29700597, author = {Portelius, E. and Olsson, B. and Höglund, K. and Cullen, N. C. and Kvartsberg, H. and Andreasson, U. and Zetterberg, H. and Å, Sandelius and others}, title = {{Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology}}, journal = {Acta neuropathologica}, year = {2018}, doi = {10.1007/s00401-018-1851-x}, pmid = {29700597}, url = {https://doi.org/10.1007/s00401-018-1851-x} } @article{alves2014-24748671, author = {Alves, G. and Lange, J. and Blennow, K. and Zetterberg, H. and Andreasson, U. and Førland, M. G. and Tysnes, O. B. and Larsen, J. P. and others}, title = {{CSF Aβ42 predicts early-onset dementia in Parkinson disease}}, journal = {Neurology}, year = {2014}, doi = {10.1212/wnl.0000000000000425}, pmid = {24748671}, url = {https://doi.org/10.1212/wnl.0000000000000425} } @article{portelius2010-20350302, author = {Portelius, E. and Dean, R. A. and Gustavsson, M. K. and Andreasson, U. and Zetterberg, H. and Siemers, E. and Blennow, K.}, title = {{A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease}}, journal = {Alzheimer's research \& therapy}, year = {2010}, doi = {10.1186/alzrt30}, pmid = {20350302}, url = {https://doi.org/10.1186/alzrt30} } @article{hellwig2015-26698298, author = {Hellwig, K. and Kvartsberg, H. and Portelius, E. and Andreasson, U. and Oberstein, T. J. and Lewczuk, P. and Blennow, K. and Kornhuber, J. and others}, title = {{Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2015}, doi = {10.1186/s13195-015-0161-y}, pmid = {26698298}, url = {https://doi.org/10.1186/s13195-015-0161-y} } @article{kovacs2017-28816001, author = {Kovacs, G. G. and Andreasson, U. and Liman, V. and Regelsberger, G. and Lutz, M. I. and Danics, K. and Keller, E. and Zetterberg, H. and others}, title = {{Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort}}, journal = {European journal of neurology}, year = {2017}, doi = {10.1111/ene.13389}, pmid = {28816001}, url = {https://doi.org/10.1111/ene.13389} } @article{dutkiewicz2020-31508810, author = {Dutkiewicz, R. and Zetterberg, H. and Andreasson, U. and Blennow, K. and Nellgård, B.}, title = {{Dementia and CSF-biomarkers for Alzheimer's disease predict mortality after acute hip fracture}}, journal = {Acta anaesthesiologica Scandinavica}, year = {2020}, doi = {10.1111/aas.13472}, pmid = {31508810}, url = {https://doi.org/10.1111/aas.13472} } @article{bjerke2011-21860087, author = {Bjerke, M. and Zetterberg, H. and Å, Edman and Blennow, K. and Wallin, A. and Andreasson, U.}, title = {{Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2011}, doi = {10.3233/jad-2011-110566}, pmid = {21860087}, url = {https://doi.org/10.3233/jad-2011-110566} } @article{gisslen2016-26870824, author = {Gisslén, M. and Price, R. W. and Andreasson, U. and Norgren, N. and Nilsson, S. and Hagberg, L. and Fuchs, D. and Spudich, S. and others}, title = {{Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study}}, journal = {EBioMedicine}, year = {2016}, doi = {10.1016/j.ebiom.2015.11.036}, pmid = {26870824}, url = {https://doi.org/10.1016/j.ebiom.2015.11.036} } @article{devos2015-26092348, author = {De Vos, A. and Jacobs, D. and Struyfs, H. and Fransen, E. and Andersson, K. and Portelius, E. and Andreasson, U. and De Surgeloose, D. and others}, title = {{C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2015}, doi = {10.1016/j.jalz.2015.05.012}, pmid = {26092348}, url = {https://doi.org/10.1016/j.jalz.2015.05.012} } @article{portelius2014-24992945, author = {Portelius, E. and Soininen, H. and Andreasson, U. and Zetterberg, H. and Persson, R. and Karlsson, G. and Blennow, K. and Herukka, S. K. and others}, title = {{Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid}}, journal = {Neuro-degenerative diseases}, year = {2014}, doi = {10.1159/000358800}, pmid = {24992945}, url = {https://doi.org/10.1159/000358800} } @article{minta2019-31156172, author = {Minta, K. and Portelius, E. and Janelidze, S. and Hansson, O. and Zetterberg, H. and Blennow, K. and Andreasson, U.}, title = {{Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2019}, doi = {10.3233/jad-190187}, pmid = {31156172}, url = {https://doi.org/10.3233/jad-190187} } @article{ohrfelt2016-27504117, author = {Öhrfelt, A. and Johansson, P. and Wallin, A. and Andreasson, U. and Zetterberg, H. and Blennow, K. and Svensson, J.}, title = {{Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease}}, journal = {Dementia and geriatric cognitive disorders extra}, year = {2016}, doi = {10.1159/000447239}, pmid = {27504117}, url = {https://doi.org/10.1159/000447239} } @article{hansson2010-18486992, author = {Hansson, O. and Zetterberg, H. and Vanmechelen, E. and Vanderstichele, H. and Andreasson, U. and Londos, E. and Wallin, A. and Minthon, L. and others}, title = {{Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment}}, journal = {Neurobiology of aging}, year = {2010}, doi = {10.1016/j.neurobiolaging.2008.03.027}, pmid = {18486992}, url = {https://doi.org/10.1016/j.neurobiolaging.2008.03.027} } @article{mielke2014-24952994, author = {Mielke, M. M. and Haughey, N. J. and Bandaru, V. V. R. and Zetterberg, H. and Blennow, K. and Andreasson, U. and Johnson, S. C. and Gleason, C. E. and others}, title = {{Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease}}, journal = {Neurobiology of aging}, year = {2014}, doi = {10.1016/j.neurobiolaging.2014.05.019}, pmid = {24952994}, url = {https://doi.org/10.1016/j.neurobiolaging.2014.05.019} } @article{sjolander2010-20849576, author = {Sjölander, A. and Zetterberg, H. and Andreasson, U. and Minthon, L. and Blennow, K.}, title = {{BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease}}, journal = {Molecular neurodegeneration}, year = {2010}, doi = {10.1186/1750-1326-5-37}, pmid = {20849576}, url = {https://doi.org/10.1186/1750-1326-5-37} }